Key Targets and Molecular Mechanisms of the Fat-soluble Components of Ginseng for Lung Cancer Treatment
-
Published:2023-03-04
Issue:11
Volume:195
Page:6495-6515
-
ISSN:0273-2289
-
Container-title:Applied Biochemistry and Biotechnology
-
language:en
-
Short-container-title:Appl Biochem Biotechnol
Author:
Gao Dongdong,Li Yingyue,Xiang Sen,Zhang Jing
Abstract
AbstractObjective: To analyze the regulatory effects and key targets of the fat-soluble components of ginseng in lung cancer. Methods: Gas chromatography–mass spectrometry and the Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform were used to analyze and identify the fat-soluble components of ginseng. Network pharmacology was used to analyze the therapeutic targets of the fat-soluble components of ginseng in lung cancer and screen key proteins. In vitro assays were conducted to verify the effects of the active fat-soluble components of ginseng on proliferation and apoptosis in lung cancer cells and to verify the regulation of key proteins. Results: Ten active fat-soluble components of ginseng were screened for follow-up. Network pharmacology showed 33 overlapping targets between the active fat-soluble components of ginseng and lung cancer, and functional enrichment of the targets showed involvement of response to nitrogen, hormone response, membrane raft, and positive regulation of external stimulus. Pathway enrichment analysis showed vascular endothelial growth factor (VEGF) signaling, adipocyte lipolysis regulation, chronic myelogenous leukemia, endocrine resistance, and NSCLC-related pathways. A protein-protein interaction network was constructed, and the top 10 targets were selected in accordance with their scores. Ultimately, five target genes (EGFR, KDR, MAPK3, PTPN11, and CTNNB1) were selected in combination with literature mining for subsequent experimental verification. Proliferation assays showed that the growth of lung cancer cells was significantly decreased in a concentration-dependent manner in the fat-soluble components of ginseng intervention group compared with controls. Flow cytometry showed that active fat-soluble components of ginseng promoted apoptosis in a concentration-dependent manner in lung cancer cells. Western blot and quantitative real-time PCR showed that levels of the five key proteins and mRNAs were significantly decreased in the intervention group; furthermore, histone protein and mRNA levels were significantly higher in the high-concentration intervention group compared with the low-concentration group. Conclusion: The active fat-soluble components of ginseng inhibited the growth of lung cancer cells and promoted apoptosis. The underlying regulatory mechanisms may be related to signaling pathways involving EGFR, KDR, MAPK3, PTPN11, and CTNNB1.
Funder
Natural Science Foundation of Henan Province
Publisher
Springer Science and Business Media LLC
Subject
Molecular Biology,Applied Microbiology and Biotechnology,Biochemistry,General Medicine,Bioengineering,Biotechnology
Reference30 articles.
1. Torre, L. A., Siegel, R. L., & Jemal, A. (2016). Lung Cancer Statistics. Advances In Experimental Medicine And Biology, 893, 1–19. 2. Hong, Q. Y., Wu, G. M., Qian, G. S., et al. (2015). Prevention and management of lung cancer in China. Cancer, 121(17), 3080–3088. 3. Baumann, M., Appold, S., Petersen, C., et al. (2001). Dose and fractionation concepts in the primary radiotherapy of non-small cell lung cancer. Lung Cancer, 33(1), S35–45. 4. Lattuca-Truc, M., Timsit, J. F., Levra, M. G., et al. (2019). Trends in response rate and survival in small-cell lung cancer patients between 1997 and 2017. Lung Cancer, 131, 122–127. 5. Zhang, X. Q., Yu, S., & Wu, S. C. (2019). Effects of ginseng polysaccharide on chemotherapy efficacy and levels of MDSCs, Treg cells and immune factors in advanced lung cancer [J]. Chinese Journal of General Practice, 17(08), 1308–1311.
|
|